Atlas FDA

MYNX ACE VASCULAR CLOSURE DEVICE

FDA premarket approval P040044/S073 · decided 2016-07-06

Approval details

PMA number
P040044
Supplement
S073
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
MYNX ACE VASCULAR CLOSURE DEVICE
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2016-06-06
Decision date
2016-07-06
Days to decision
30 days
Decision code
OK30
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
Add a second sterilization line at a previously approved alternate sterilization facility (Synergy Health in San Diego, California).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.